Oklo (NYSE: OKLO) has seen a dramatic shift in its stock performance, plummeting 15% over the past three months after a staggering 238% gain in 2025. As investors reassess the nuclear energy company’s current standing against its previous hype, questions arise about whether this downturn presents a buying opportunity or simply highlights the inherent risks of investing in a company still awaiting regulatory approval for its reactor designs.
The company is developing small fast-spectrum reactors, known as Aurora powerhouses, aimed at providing on-site power for various applications. However, Oklo faces significant challenges, including fuel supply constraints and the absence of an operational reactor, which is not expected until late 2027 or 2028. The reliance on high-assay low-enriched uranium (HALEU) and the limited current supply from Centrus Energy raises concerns about the feasibility of its ambitious plans.
For market professionals, the key takeaway is that while Oklo’s long-term potential remains intriguing, the next two years are likely to be marked by speculation and volatility. Investors should weigh the risks carefully as the company navigates a complex landscape of regulatory and supply chain hurdles.
Source: fool.com